Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. - Wikidata - awgldk - TriplyDB

Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.

Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.

http://www.wikidata.org/entity/Q33670824

about

Multimodal management of muscle-invasive bladder cancer Evolution of urological imaging Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.Evaluation of 11C-choline PET/CT for primary diagnosis and staging of urothelial carcinoma of the upper urinary tract: a pilot study Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience.Efficacy of (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy.PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer.PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder Cancer Detecting Metastatic Bladder Cancer Using (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.PET/CT and MRI in Bladder Cancer.Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer.Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer.The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers.Latest developments in imaging of bladder cancer.Urothelial carcinoma of the bladder: definition, treatment and future efforts.Neoadjuvant chemotherapy for invasive bladder cancer.Update on use of enhanced imaging to optimize lymphadenectomy in patients undergoing minimally invasive surgery for urothelial cancer of the bladder.Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy.Current role of PET, CT, MR for invasive bladder cancer.USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.Preoperative imaging for staging bladder cancer.Diagnostic value of [18F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis.Current Staging Procedures in Urinary Bladder Cancer The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis.Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy.Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.Advances in medical imaging for the diagnosis and management of common genitourinary cancers.Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer.Comparing RECIST with EORTC criteria in metastatic bladder cancer.Apparent diffusion coefficient on magnetic resonance imaging (MRI) in bladder cancer: relations with recurrence/progression risk.Endoscopic-ultrasound-guided tissue sampling facilitates the detection of local recurrence and extra pelvic metastasis in pelvic urologic malignancy.Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer.Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis.Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancer.[Pharmacological therapy of urogenital cancer: rational routine diagnostic imaging].Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.

P2860

Q27011624-C0C37CEE-0D2F-4A48-A1BE-946B841AE3D3 Q27692114-723D6462-9F5B-41F2-9050-BCAD583BA928 Q28072814-E4233961-FB6F-4FC3-9BC8-340E921C80C3 Q28084159-08364369-2762-41A5-81F0-6F9CC619E9C8 Q30421675-C2379366-2059-4464-A235-34C0712C1B48 Q34131787-313FC206-8A9B-4820-9804-9D38049B99B2 Q34485009-78EEE7BB-58A1-41B5-B8B4-9A6EB8B24ACF Q35014729-D6AC40F7-977D-45EF-B28F-11AF5EEF1079 Q35048726-ABDA1C04-A802-4F74-8F9A-5D2D6640F3EE Q35751887-62DFE20E-336C-4F29-A2A9-51D3BDE855A5 Q35776939-D6945863-B734-43BE-A345-FCA69968209C Q35828369-356F2178-9914-452C-95F7-C89BF8FD687C Q36187084-686D96D4-96A4-4BC0-9E3B-99468D1EEB18 Q36654987-453DAF93-D7EA-4467-A38D-A63F7758414E Q37565552-7AFCFC41-7345-476B-9FA0-FD70A15E22D2 Q37679778-355A3B44-3A9B-4C8C-93D7-B0BFC8700B94 Q37725130-5B48D8DB-6759-4172-A46D-01C8D852416A Q37765587-F29699E6-6B7D-4F2E-92D0-6EDE5526A233 Q37944437-CEA438EF-B130-49F0-986D-4E30B078CB09 Q37982318-A5DEFB60-10F3-4255-9B26-B8FB8085F175 Q38076094-76A90B95-3364-41C1-B5B3-8CC90F63508B Q38077272-BB733A66-17AE-466A-A48C-ACF4A8838533 Q38080034-28E76E99-8CE1-4FAC-BC5C-7382CC13CD11 Q38152780-F8247C2C-5C51-42A0-A321-07217FCF2667 Q38365924-E423E1F9-2809-47DF-B621-18187A7AAFF8 Q38391343-8AF58632-FF91-45EC-8649-5107BAF883FD Q38715998-41962ADA-EC11-4B7D-9449-198FA9E10D42 Q38723570-32443A39-D9CA-4E20-B276-0888AED99836 Q38901788-53ECA37E-8931-4BF3-A4FC-79712498A88A Q39254614-7E1BAA69-5125-4B70-829A-D0E917258166 Q39307896-197C25D9-3B21-47E0-822C-DEE4B4FA8AB5 Q40076302-700CCE04-C7B5-4475-958F-75E4D3E14065 Q40699016-31DD14EE-B8EE-4F18-8DAB-0F6129A3BB5F Q41129219-389B34EA-0FDE-42F4-B20D-8CFE69081CF3 Q42055549-38475E2E-360F-4387-88D0-EBF1C9BCF0A4 Q42451041-D7ECDE7E-947E-444D-A8BD-CA7BB939A748 Q43066911-82FED21B-7DB3-4E85-8BEA-528F22D2310F Q43500397-92315208-0987-407C-9961-8A40D86D8DA4 Q44017338-5C92EFD1-5C1A-418B-A8E1-7C4B1A0F1B6B Q44978946-52C650E1-1AAD-467F-91A0-92B8DE5590B1

P2860

Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.

http://www.wikidata.org/entity/Q33670824

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Prospective study of [18F]fluo ...... le-invasive bladder carcinoma.

@ast

Prospective study of [18F]fluo ...... le-invasive bladder carcinoma.

@en

type

label

Prospective study of [18F]fluo ...... le-invasive bladder carcinoma.

@ast

Prospective study of [18F]fluo ...... le-invasive bladder carcinoma.

@en

prefLabel

Prospective study of [18F]fluo ...... le-invasive bladder carcinoma.

@ast

Prospective study of [18F]fluo ...... le-invasive bladder carcinoma.

@en

P1433

Q33670824-18773C80-3FA9-4085-BD2F-3BBDBE9B2DD0

P1476

Q33670824-16E210A7-2B89-4F4F-ADC8-F409F23B7692

P2093

Q33670824-2A5FF109-E7EC-41CC-B09C-F44A236A9205

Q33670824-516F0407-5F64-4965-B5E4-651A369D4894

Q33670824-790F0EDF-120F-4D85-B6E9-FC85855816F6

Q33670824-7C14371C-04A8-49AD-81AB-A45B90ADA847

Q33670824-981C99E4-2BD2-4F76-9ACB-0A2D4DAA5E31

Q33670824-A01C9074-D931-410C-8C7B-D7B96D44CFB9

Q33670824-C337EA64-4A5B-46AE-AC23-3C12495A2385

Q33670824-CCEFCDFB-79B1-4520-B711-9253AE2C35BD

Q33670824-FF46CB6F-1545-4823-BE0F-2074AE9E56F4

P2860

Q33670824-0B28D006-3527-47B7-BD5E-DA5C0C3F1FDB

Q33670824-35F3EEE6-31FB-4346-8619-5D8FD202FAD3

Q33670824-3BFFCA9E-FA35-442D-89BA-A5982B5A8625

Q33670824-5B37F042-ABA3-4B2F-8F79-5AA07BACDA35

Q33670824-63EEDB29-CF12-4A9B-B42D-A33AF5B44060

Q33670824-645F77C1-4F2F-4EDC-B3EF-6BE3554ED922

Q33670824-68646374-681E-4915-91A1-D23E307F11EF

Q33670824-89E3D3B5-69AB-40FE-B7CA-83FDFC100CA8

Q33670824-8A7450FE-B081-4A50-8DC5-E45DA2A895AF

Q33670824-A0970F79-4452-4761-A063-B8FD6FD4670A

P304

Q33670824-26E519A0-9068-4469-960F-DE696211BBCB

P31

Q33670824-29386CED-AA4E-4B5A-9D5B-81E9F83F68B1

P356

Q33670824-314CBAFB-A98C-4C47-A448-B3423E4F44FC

P407

Q33670824-0BD1F4D0-CFA4-47CB-BF6D-833202E68394

P433

Q33670824-418299ED-291A-4516-818E-C9670117BA77

P478

Q33670824-C78782AB-EFCF-4D1A-BD6F-3E7D127CFB76

P50

Q33670824-124EA844-BAB5-4051-B00B-A0576F263A3E

P577

Q33670824-C781FE03-AC82-421B-8854-89C1BFBCAF45

P5875

Q33670824-06553D5C-DD5F-4ACB-A293-ECC4BC050E95

P698

Q33670824-253C3EDD-F39F-49E7-9B67-D0EC04A94A54

P932

Q33670824-2A385CEC-CD8A-4B17-BB1D-5C51526797A4

P356

JCO.2008.20.6722

P1433

Journal of Clinical Oncology

P1476

Prospective study of [18F]fluo ...... le-invasive bladder carcinoma.

@en

P2093

Adam S Kibel

http://www.w3.org/2001/XMLSchema#string

Aleksandra P Klim

http://www.w3.org/2001/XMLSchema#string

Barry A Siegel

http://www.w3.org/2001/XMLSchema#string

Cary Siegel

http://www.w3.org/2001/XMLSchema#string

Dengfeng Cao

http://www.w3.org/2001/XMLSchema#string

Farrokh Dehdashti

http://www.w3.org/2001/XMLSchema#string

Matthew D Katz

http://www.w3.org/2001/XMLSchema#string

Peter A Humphrey

http://www.w3.org/2001/XMLSchema#string

Robert L Grubb

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods.

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis.

Integrated PET/CT: current applications and future directions.

[F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma

Optimizing therapeutic strategies in advanced bladder cancer: update on chemotherapy and the role of targeted agents.

Diagnostic imaging of urothelial cancer.

P304

4314-4320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.20.6722

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26714346

http://www.w3.org/2001/XMLSchema#string

P698

19652070

http://www.w3.org/2001/XMLSchema#string

P932

4035361

http://www.w3.org/2001/XMLSchema#string